Your browser doesn't support javascript.
loading
Therapeutic Effects of Quetiapine and 5-HT1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice.
Ochiai, Yukiko; Fujita, Masayo; Hagino, Yoko; Kobayashi, Kazuto; Okiyama, Ryoichi; Takahashi, Kazushi; Ikeda, Kazutaka.
Affiliation
  • Ochiai Y; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Fujita M; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo 183-0042, Japan.
  • Hagino Y; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Kobayashi K; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Okiyama R; Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University, Fukushima 960-1295, Japan.
  • Takahashi K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo 183-0042, Japan.
  • Ikeda K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo 183-0042, Japan.
Int J Mol Sci ; 23(13)2022 Jul 04.
Article in En | MEDLINE | ID: mdl-35806448

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Dopamine / Receptor, Serotonin, 5-HT1A / Serotonin 5-HT1 Receptor Agonists / Quetiapine Fumarate Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Dopamine / Receptor, Serotonin, 5-HT1A / Serotonin 5-HT1 Receptor Agonists / Quetiapine Fumarate Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Japan